CAR T Cell Therapy for Neuroblastoma

od Richards, Rebecca M., Sotillo, Elena, Majzner, Robbie G.
Wydane w Front Immunol (2018)

IMMU-55. GD2 IS A MACROPHAGE CHECKPOINT MOLECULE AND COMBINED GD2/CD47 BLOCKADE RESULTS IN SYNERGISTIC EFFECTS AGAINST GD2 POSITIVE MALIGNANCIES

od Theruvath, Johanna, Mount, Christopher, Monje, Michelle, Mackall, Crystal, Majzner, Robbie
Wydane w Neuro Oncol (2020)

Immune-Based Approaches for the Treatment of Pediatric Malignancies

od Bosse, Kristopher R., Majzner, Robbie G., Mackall, Crystal L., Maris, John M.
Wydane w Annu Rev Cancer Biol (2020)

IMMU-09. LOCALLY ADMINISTERED CAR T CELLS DEMONSTRATE MOST FAVORABLE ROUTE OF ADMINISTRATION IN A MODEL OF ATRT

od Theruvath, Johanna, Graef, Claus Moritz, Heitzeneder, Sabine, Majzner, Robbie, Labanieh, Louai, Mackall, Crystal
Wydane w Neuro Oncol (2019)

PDTM-39. GD2-DIRECTED CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA

od Mount, Christopher, Majzner, Robbie, Sundaresh, Shree, Arnold, Evan, Kadapakkam, Meena, Monje-Deisseroth, Michelle, Mackall, Crystal
Wydane w Neuro Oncol (2017)

ATRT-25. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON ATYPICAL RHABDOID TERATOID TUMOR (ATRT) AND IS A PROMISING CANDIDATE FOR CAR T CELL THERAPY

od Theruvath, Johanna, Graef, Claus-Moritz, Heitzeneder, Sabine, Majzner, Robbie, Mitra, Siddhartha, Cheshier, Samuel H, Mackall, Crystal
Wydane w Neuro Oncol (2018)

IMMU-07. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON MEDULLOBLASTOMA AND PROVES TO BE A PROMISING CANDIDATE FOR CAR T CELL IMMUNOTHERAPY

od Theruvath, Johanna, Heitzeneder, Sabine, Majzner, Robbie, Moritz Graef, Claus, Cui, Karen, Nellan, Anandani, H Cheshier, Samuel, Mackall, Crystal, Mitra, Siddhartha
Wydane w Neuro Oncol (2017)

IMMU-45. CHECKPOINT MOLECULE B7-H3 IS HIGHLY EXPRESSED ON MEDULLOBLASTOMA AND PROVES TO BE A PROMISING CANDIDATE FOR CAR T CELL IMMUNOTHERAPY

od Theruvath, Johanna, Heitzeneder, Sabine, Majzner, Robbie, Cui, Karen, Nellan, Anandani, Graef, Claus Moritz, Cheshier, Samuel H, Mackall, Crystal, Mitra, Siddhartha S
Wydane w Neuro Oncol (2017)

DIPG-36. ANTI-GD2 CHIMERIC ANTIGEN RECEPTOR T CELLS AS A POTENT IMMUNOTHERAPY REGIMEN IN XENOGRAFT MODELS OF HISTONE 3 K27M MUTANT DIFFUSE MIDLINE GLIOMA

od Mount, Christopher, Majzner, Robbie, Sundaresh, Shree, Arnold, Evan, Kadapakkam, Meena, Haile, Samuel, Labanieh, Louai, Woo, Pamelyn, Rietberg, Skyler, Vogel, Hannes, Monje, Michelle, Mackall, Crystal
Wydane w Neuro Oncol (2018)

Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells

od Nellan, Anandani, Rota, Christopher, Majzner, Robbie, Lester-McCully, Cynthia M., Griesinger, Andrea M., Mulcahy Levy, Jean M., Foreman, Nicholas K., Warren, Katherine E., Lee, Daniel W.
Wydane w J Immunother Cancer (2018)

Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report

od Schultz, Liora, Patel, Shabnum, Davis, Kara Lynn, Ramakrishna, Sneha, Sahaf, Bita, Bhatia, Neehar, Baggott, Christina, Erickson, Courtney, Majzner, Robbie G, Oak, Jean, Bertaina, Alice, Mackall, Crystal, Feldman, Steven
Wydane w J Immunother Cancer (2020)

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

od Walker, Alec J., Majzner, Robbie G., Zhang, Ling, Wanhainen, Kelsey, Long, Adrienne H., Nguyen, Sang M., Lopomo, Paola, Vigny, Marc, Fry, Terry J., Orentas, Rimas J., Mackall, Crystal L.
Wydane w Mol Ther (2017)

Post-Transplant Cyclophosphamide after Bone Marrow Transplantation is not Associated with an Increased Risk of Donor Derived Malignancy

od Majzner, Robbie G., Mogri, Huzefa, Varadhan, Ravi, Brown, Patrick, Cooke, Kenneth R., Bolaños-Meade, Javier, Swinnen, Lode, Kanakry, Jennifer, Luznik, Leo, Jones, Rick, Fuchs, Ephraim, Ambinder, Rich, Kasamon, Yvette, Symons, Heather J.
Wydane w Biol Blood Marrow Transplant (2017)

Potent antitumor efficacy of anti-GD2 CAR T-cells in H3K27M+ diffuse midline gliomas

od Mount, Christopher W., Majzner, Robbie G., Sundaresh, Shree, Arnold, Evan P., Kadapakkam, Meena, Haile, Samuel, Labanieh, Louai, Hulleman, Esther, Woo, Pamelyn J., Rietberg, Skyler P., Vogel, Hannes, Monje, Michelle, Mackall, Crystal L.
Wydane w Nat Med (2018)

Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins

od Blaeschke, Franziska, Stenger, Dana, Apfelbeck, Antonia, Cadilha, Bruno L., Benmebarek, Mohamed-Reda, Mahdawi, Jasmin, Ortner, Eva, Lepenies, Mareike, Habjan, Nicola, Rataj, Felicitas, Willier, Semjon, Kaeuferle, Theresa, Majzner, Robbie G., Busch, Dirk H., Kobold, Sebastian, Feuchtinger, Tobias
Wydane w Blood Cancer J (2021)

c-Jun overexpression in CAR T cells induces exhaustion resistance

od Lynn, Rachel C., Weber, Evan W., Sotillo, Elena, Gennert, David, Xu, Peng, Good, Zinaida, Anbunathan, Hima, Lattin, John, Jones, Robert, Tieu, Victor, Nagaraja, Surya, Granja, Jeffrey, DeBourcy, Charles, Majzner, Robbie, Satpathy, Ansuman T., Quake, Stephen R., Monje, Michelle, Chang, Howard, Mackall, Crystal L.
Wydane w Nature (2019)

Immune receptor inhibition through enforced phosphatase recruitment

od Fernandes, Ricardo A., Su, Leon, Nishiga, Yoko, Ren, Junming, Bhuiyan, Aladdin M., Cheng, Ning, Kuo, Calvin J., Picton, Lora K., Ohtsuki, Shozo, Majzner, Robbie G., Rietberg, Skyler P., Mackall, Crystal L., Yin, Qian, Ali, Lestat R., Yang, Xinbo, Savvides, Christina S., Sage, Julien, Dougan, Michael, Garcia, K. Christopher
Wydane w Nature (2020)

Tuning the Antigen Density Requirement for CAR T Cell Activity

od Majzner, Robbie G., Rietberg, Skyler P., Sotillo, Elena, Dong, Rui, Vachharajani, Vipul T., Labanieh, Louai, Myklebust, June H., Kadapakkam, Meena, Weber, Evan W., Tousley, Aidan M., Richards, Rebecca M., Heitzeneder, Sabine, Nguyen, Sang M., Wiebking, Volker, Theruvath, Johanna, Lynn, Rachel C., Xu, Peng, Dunn, Alexander R., Vale, Ronald D., Mackall, Crystal L.
Wydane w Cancer Discov (2020)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL

od Fry, Terry J., Shah, Nirali N., Orentas, Rimas J., Stetler-Stevenson, Maryalice, Yuan, Constance M., Ramakrishna, Sneha, Wolters, Pamela, Martin, Staci, Delbrook, Cindy, Yates, Bonnie, Shalabi, Haneen, Fountaine, Thomas J., Shern, Jack F., Majzner, Robbie G., Stroncek, David F., Sabatino, Marianna, Feng, Yang, Dimitrov, Dimiter S., Zhang, Ling, Nguyen, Sang, Qin, Haiying, Dropulic, Boro, Lee, Daniel W., Mackall, Crystal L.
Wydane w Nat Med (2017)

Transient “rest” restores functionality in exhausted CAR-T cells via epigenetic remodeling

od Weber, Evan W., Parker, Kevin R., Sotillo, Elena, Lynn, Rachel C., Anbunathan, Hima, Lattin, John, Good, Zinaida, Belk, Julia A., Daniel, Bence, Klysz, Dorota, Malipatlolla, Meena, Xu, Peng, Bashti, Malek, Heitzeneder, Sabine, Labanieh, Louai, Vandris, Panayiotis, Majzner, Robbie G., Qi, Yanyan, Sandor, Katalin, Chen, Ling-Chun, Prabhu, Snehit, Gentles, Andrew J., Wandless, Thomas J., Satpathy, Ansuman T., Chang, Howard Y., Mackall, Crystal L.
Wydane w Science (2021)